Edward M. Driscoll

1.3k total citations
41 papers, 1.1k citations indexed

About

Edward M. Driscoll is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Edward M. Driscoll has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pathology and Forensic Medicine and 8 papers in Hematology. Recurrent topics in Edward M. Driscoll's work include Cardiac Ischemia and Reperfusion (15 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Edward M. Driscoll is often cited by papers focused on Cardiac Ischemia and Reperfusion (15 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Edward M. Driscoll collaborates with scholars based in United States, France and Germany. Edward M. Driscoll's co-authors include Benedict R. Lucchesi, Michael J. Shea, S.W. Werns, Bertram Pitt, Gerald D. Abrams, James K. Hennan, Michael Gralinski, Gregory S. Friedrichs, Jinbao Huang and Terrance D. Barrett and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Edward M. Driscoll

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward M. Driscoll United States 19 512 312 201 152 118 41 1.1k
Michael Gralinski United States 18 343 0.7× 150 0.5× 199 1.0× 51 0.3× 62 0.5× 32 709
Laura Casaní Spain 24 448 0.9× 218 0.7× 383 1.9× 48 0.3× 98 0.8× 50 1.3k
Liguo Chi United States 16 413 0.8× 191 0.6× 422 2.1× 26 0.2× 45 0.4× 40 991
J. A. Rousou United States 19 351 0.7× 635 2.0× 449 2.2× 38 0.3× 193 1.6× 30 1.4k
Dongdan Zheng China 21 293 0.6× 115 0.4× 402 2.0× 56 0.4× 169 1.4× 30 1.2k
Jan‐Arne Björkman Sweden 16 522 1.0× 48 0.2× 240 1.2× 44 0.3× 45 0.4× 38 919
Takio Shimamoto Japan 19 432 0.8× 55 0.2× 235 1.2× 116 0.8× 86 0.7× 105 1.1k
A J Marcus United States 7 296 0.6× 52 0.2× 206 1.0× 251 1.7× 189 1.6× 10 1.0k
J Mehta United States 13 255 0.5× 97 0.3× 110 0.5× 20 0.1× 80 0.7× 29 651
David A. Tulis United States 21 218 0.4× 118 0.4× 827 4.1× 109 0.7× 316 2.7× 46 1.4k

Countries citing papers authored by Edward M. Driscoll

Since Specialization
Citations

This map shows the geographic impact of Edward M. Driscoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M. Driscoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M. Driscoll more than expected).

Fields of papers citing papers by Edward M. Driscoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward M. Driscoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M. Driscoll. The network helps show where Edward M. Driscoll may publish in the future.

Co-authorship network of co-authors of Edward M. Driscoll

This figure shows the co-authorship network connecting the top 25 collaborators of Edward M. Driscoll. A scholar is included among the top collaborators of Edward M. Driscoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward M. Driscoll. Edward M. Driscoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lauver, Adam, Edward M. Driscoll, & Benedict R. Lucchesi. (2008). Disodium Disuccinate Astaxanthin Prevents Carotid Artery Rethrombosis and ex vivo Platelet Activation. Pharmacology. 82(1). 67–73. 23 indexed citations
2.
Hennan, James K., Edward M. Driscoll, Terrance D. Barrett, Peter Fischbach, & Benedict R. Lucchesi. (2006). Effect of Sodium/Hydrogen Exchange Inhibition on Myocardial Infarct Size after Coronary Artery Thrombosis and Thrombolysis. Pharmacology. 78(1). 27–37. 4 indexed citations
3.
Miller, Douglas L., Edward M. Driscoll, Chunyan Dou, William F. Armstrong, & Benedict R. Lucchesi. (2006). Microvascular Permeabilization and Cardiomyocyte Injury Provoked by Myocardial Contrast Echocardiography in a Canine Model. Journal of the American College of Cardiology. 47(7). 1464–1468. 44 indexed citations
4.
Driscoll, Edward M., et al.. (2006). Preclinical Evaluation of S18886 in an Experimental Model of Coronary Arterial Thrombosis. Journal of Cardiovascular Pharmacology. 48(5). 239–248. 24 indexed citations
5.
Huang, Jinbao, et al.. (2005). The Antithrombotic Effect of Melagatran in Combination With Clopidogrel and/or Aspirin (carotid artery primary thrombosis study). Journal of Cardiovascular Pharmacology. 46(4). 526–533. 12 indexed citations
6.
7.
Hennan, James K., et al.. (2003). Prevention of Carotid Artery Thrombosis After Oral Administration of the Glycoprotein IIb/IIIa Antagonist CRL42796. Journal of Cardiovascular Pharmacology. 42(1). 71–77. 3 indexed citations
8.
Hennan, James K., et al.. (2002). Intimatan Prevents Arterial and Venous Thrombosis in a Canine Model of Deep Vessel Wall Injury. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1151–1156. 18 indexed citations
9.
Hennan, James K., et al.. (2002). Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796. British Journal of Pharmacology. 136(6). 927–937. 9 indexed citations
10.
Barrett, Terrance D., James K. Hennan, Peter Fischbach, et al.. (2001). Tedisamil and dofetilide‐induced torsades de pointes, rate and potassium dependence. British Journal of Pharmacology. 132(7). 1493–1500. 16 indexed citations
11.
Driscoll, Edward M., et al.. (2000). Prevention of Arterial Thrombosis by Intravenously Administered Platelet P2T Receptor Antagonist AR-C69931MX in a Canine Model. Journal of Pharmacology and Experimental Therapeutics. 295(2). 492–499. 37 indexed citations
12.
Friedrichs, Gregory S., et al.. (1998). Antifibrillatory Efficacy of Long-Term Tedisamil Administration in a Postinfarcted Canine Model of Ischemic Ventricular Fibrillation. Journal of Cardiovascular Pharmacology. 31(1). 56–66. 20 indexed citations
13.
Black, Shawn C., Edward M. Driscoll, & B R Lucchesi. (1998). Effect of Ramiprilat or Captopril on Myocardial Infarct Size: Assessment in Canine Models of Ischemia Alone and Ischemia with Reperfusion. Pharmacology. 57(1). 35–46. 6 indexed citations
14.
15.
Gralinski, Michael, et al.. (1996). Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion. Journal of Cardiovascular Pharmacology and Therapeutics. 1(3). 219–228. 17 indexed citations
16.
Minami, Masaru, Edward M. Driscoll, Paul J. Simpson, Paul Hoff, & Benedict R. Lucchesi. (1995). Effects of BMY21190, an Inhibitor of cAMP Phosphodiesterase, on Infarct Size and Myeloperoxidase Activity in the Ischemic Myocardium of a Canine Occlusion-Reperf usion Model. Pharmacology. 50(1). 24–33. 3 indexed citations
17.
Minami, Masaru, Masahiko Hirafuji, Edward M. Driscoll, & Benedict R. Lucchesi. (1994). BMY21190, A Potent Inhibitor of cAMP Phosphodiesterase. Cardiovascular Drug Reviews. 12(2). 173–192. 2 indexed citations
18.
Lynch, Joseph J., Andrew C. G. Uprichard, John Frye, et al.. (1989). Effects of the Positive Inotropic Agents Milrinone and Pimobendan on the Development of Lethal Ischemic Arrhythmias in Conscious Dogs with Recent Myocardial Infarction. Journal of Cardiovascular Pharmacology. 14(4). 585–597. 21 indexed citations
19.
Uprichard, Andrew C. G., Liguo Chi, Joseph J. Lynch, et al.. (1989). Alinidine Reduces the Incidence of Ischemic Ventricular Fibrillation in a Conscious Canine Model, a Protective Effect Antagonized by Overdrive Atrial Pacing. Journal of Cardiovascular Pharmacology. 14(3). 475–482. 8 indexed citations
20.
Murtagh, James J., Edward M. Driscoll, S. Jolly, et al.. (1983). Beneficial Effects of Nafazatrom in Experimental Models of Coronary Thrombosis and Myocardial Ischemia. European Heart Journal. 4(suppl B). 2–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Gralinski Breakdown of academic impact, for papers by Laura Casaní Breakdown of academic impact, for papers by Liguo Chi Breakdown of academic impact, for papers by J. A. Rousou Breakdown of academic impact, for papers by Dongdan Zheng Breakdown of academic impact, for papers by Jan‐Arne Björkman Breakdown of academic impact, for papers by Takio Shimamoto Breakdown of academic impact, for papers by A J Marcus Breakdown of academic impact, for papers by J Mehta Breakdown of academic impact, for papers by David A. Tulis
Rankless by CCL
2026